Ogenix Revenue and Competitors
Estimated Revenue & Valuation
- Ogenix's estimated annual revenue is currently $2.5M per year.
- Ogenix's estimated revenue per employee is $358,571
Employee Data
- Ogenix has 7 Employees.
- Ogenix grew their employee count by -12% last year.
Ogenix's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP Operations | Reveal Email/Phone |
3 | Medical Director | Reveal Email/Phone |
4 | Director Podiatric Medicine and Wound Care | Reveal Email/Phone |
5 | Regional sales manager | Reveal Email/Phone |
Ogenix Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5M | 40 | -18% | $10M | N/A |
#2 | $24.8M | 99 | 29% | N/A | N/A |
#3 | $84.1M | 0 | N/A | $1.2M | N/A |
#4 | $35.6M | 142 | 30% | N/A | N/A |
#5 | $57.5M | 211 | 12% | N/A | N/A |
#6 | $52.7M | 168 | 25% | $129.6M | N/A |
#7 | $21.1M | 64 | -7% | N/A | N/A |
#8 | $61.2M | 215 | 8% | N/A | N/A |
#9 | $60.6M | 193 | 20% | $115.5M | N/A |
#10 | $56.2M | 179 | -3% | $122.9M | N/A |
What Is Ogenix?
Ogenix is the manufacturer of EPIFLO, an FDA cleared, 3 ounce, 24/7 oxygen therapy which effectively treats many chronic wounds such as diabetic foot ulcers, venous stasis, pressure sores or bed sores (decubitus), surgical wounds, burns and many others.
keywords:N/A
N/A
Total Funding
7
Number of Employees
$2.5M
Revenue (est)
-12%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.7M | 7 | 40% | N/A |
#2 | $0.1M | 7 | 0% | $6.1M |
#3 | $3.5M | 7 | -30% | N/A |
#4 | $1.4M | 7 | -36% | N/A |
#5 | $0.5M | 7 | N/A | N/A |